liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Overall Survival Benefit for Sequential Doxorubicin-Docetaxel Compared to Concomitant Doxorubicin and Docetaxel in Node-Positive Breast Cancer. 8-Yr. Results of the Breast International Group (BIG) 2-98 Phase III Adjuvant Trial in CANCER RESEARCH, vol 69, issue 24, pp 521S-521S
External - unknown .
External - unknown .
External - unknown .
External - unknown .
Show others and affiliations
2009 (English)In: CANCER RESEARCH, 2009, Vol. 69, no 24, 521S-521S p.Conference paper, Published paper (Refereed)
Abstract [en]

n/a

Place, publisher, year, edition, pages
2009. Vol. 69, no 24, 521S-521S p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-53830ISI: 000272920700115OAI: oai:DiVA.org:liu-53830DiVA: diva2:292209
Available from: 2010-02-05 Created: 2010-02-05 Last updated: 2010-02-05

Open Access in DiVA

No full text

Authority records BETA

Nordenskjöld, Bo

Search in DiVA

By author/editor
Nordenskjöld, Bo
By organisation
Oncology Faculty of Health SciencesDepartment of Oncology UHL
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 45 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf